Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is December - November.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021
Cash & Equivalents	246.96	110	54.63	64.47	80.51
Short-Term Investments	345.98	499.59	233.28	244.67	215.21
Cash & Short-Term Investments	592.94	609.58	287.91	309.14	295.72
Cash Growth	-2.73%	111.73%	-6.87%	4.54%	5.18%
Accounts Receivable	-	-	-	-	6
Other Receivables	1.5	1.5	0.8	1.1	1.1
Receivables	1.5	1.5	0.8	1.1	7.1
Prepaid Expenses	12.38	8.3	6.8	8.21	8.29
Total Current Assets	606.82	619.39	295.5	318.45	311.12
Property, Plant & Equipment	73.01	45.9	47.95	29.51	25.35
Long-Term Investments	-	-	7.42	63.88	137.19
Long-Term Deferred Charges	0.1	0.1	0.5	0.5	0.5
Other Long-Term Assets	8.21	3.96	4.22	4.42	2.62
Total Assets	688.14	669.34	355.6	416.76	476.77
Accounts Payable	11.22	11.48	6.4	5.06	6.65
Accrued Expenses	51.7	34.48	24.19	20.84	13.82
Current Portion of Leases	2.82	8.01	7.49	5.53	3.85
Current Income Taxes Payable	1.06	1.24	0.03	0.09	0.08
Current Unearned Revenue	17.58	38.36	48.1	37.63	41.21
Other Current Liabilities	2.1	2.28	0.75	1.5	0.66
Total Current Liabilities	86.47	95.85	86.96	70.66	66.26
Long-Term Leases	52.91	20.29	23.13	6.43	9.19
Long-Term Unearned Revenue	10.01	26.21	45.02	35.97	59.02
Total Liabilities	149.39	142.35	155.11	113.06	134.47
Common Stock	0.1	0.08	0.05	0.05	0.05
Additional Paid-In Capital	1,542	1,266	746.3	709.22	563.76
Retained Earnings	-1,003	-738.77	-545.2	-401.25	-220.89
Comprehensive Income & Other	0.11	0.15	-0.66	-4.32	-0.61
Total Common Equity	538.75	526.99	200.49	303.7	342.3
Shareholders' Equity	538.75	526.99	200.49	303.7	342.3
Total Liabilities & Equity	688.14	669.34	355.6	416.76	476.77
Total Debt	55.73	28.3	30.61	11.96	13.04
Net Cash (Debt)	537.21	581.28	264.72	361.06	419.87
Net Cash Growth	-7.58%	119.59%	-26.68%	-14.01%	49.34%
Net Cash Per Share	6.20	8.66	4.87	7.43	9.79
Filing Date Shares Outstanding	102.84	75.89	48.89	47.27	44.74
Total Common Shares Outstanding	101.81	75.87	48.72	47.17	44.66
Working Capital	520.35	523.53	208.55	247.79	244.86
Book Value Per Share	5.29	6.95	4.12	6.44	7.66
Tangible Book Value	538.75	526.99	200.49	303.7	342.3
Tangible Book Value Per Share	5.29	6.95	4.12	6.44	7.66
Machinery	44.75	41.04	33.83	27.62	19.3
Leasehold Improvements	9.37	5.14	3.24	3.83	3.08

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q